<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Cataland, Spero R.</style></author><author><style face="normal" font="default" size="100%">Vesely, Sara K.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Advances in Understanding and Treatment of Thrombotic Thrombocytopenia Purpura</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-08-10 10:58:07</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-12</style></pages><abstract><style  face="normal" font="default" size="100%">It becomes apparent that thrombotic thrombocytopenia purpura is an acute life-threatening condition that can be complicated with multiple recurrences and long-term microvascular damages. In contrast with previous thought, thrombotic thrombocytopenia purpura does not appear to pose an appreciable risk in pregnancy. The new modality of treatment options may help to reduce the severity of acute illness and prevent further relapse.</style></abstract><number><style face="normal" font="default" size="100%">21</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>